Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg
Clinical trial NCT00648336 · COMPLETED
Trial details
- NCT number
- NCT00648336
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2003-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.